Medical conditions associated with recurrent miscarriage-Is BMI the tip of the iceberg?

被引:18
作者
Matjila, Mushi J. [1 ,2 ]
Hoffman, Anne [1 ]
van der Spuy, Zephne M. [1 ]
机构
[1] Groote Schuur Hosp, Dept Obstet & Gynaecol, ZA-7937 Cape Town, South Africa
[2] Univ Cape Town, Div Med Biochem, Inst Infect Dis & Mol Med, MRC UCT Receptor Biol Unit, ZA-7925 Cape Town, Western Cape, South Africa
关键词
Recurrent miscarriage; Polycystic ovary syndrome; Impaired glucose tolerance; Obesity; POLYCYSTIC-OVARY-SYNDROME; BODY-MASS INDEX; WOMEN; CONCEPTION; OBESITY; RISK; INFERTILITY; INCREASE; OUTCOMES; AFRICA;
D O I
10.1016/j.ejogrb.2017.05.003
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Background: In contrast to sporadic miscarriage, recurrent miscarriage (RM) is a rare entity which affects 1% of couples attempting conception. It is distressing for couples and healthcare professionals as the aetiology is unclear with limited treatment options. Apart from anti-phospholipid syndrome (APS), the strength of associations between RM and commonly investigated endocrine, autoimmune, thrombophilic and uterine structural abnormalities remains uncertain and variable. Objectives: To assess the prevalence of commonly investigated medical conditions associated with RM. Study design: A 9-year retrospective analysis of a prospectively collected database was conducted for 592 patients seen between 2008 and 2016, in tertiary level RM clinic in South Africa. Results: In this period, 592 patients were assessed. The mean age was 29.73 +/- 5.46 (mean +/- SD), gravidity 4.6 +/- 1.82 and parity 0.98 +/- 1.05. The mean number of miscarriages per patient was 3.34 +/- 1.63, of which two-thirds (61.3%) were in the first trimester, a third (33%) in the second trimester and intrauterine fetal deaths (IUFDs) constituted 6% of total losses. Of the 50% of patients with no identified associated disorders, 15% were unexplained (investigations complete but no associations found), 10% became pregnant during investigation (investigations incomplete) and 25% were lost to follow-up (investigations incomplete). Nearly forty percent (38%) of patients had an associated endocrine disorder (22% PCOS, 11% IGT, 3% Diabetes Mellitus and 2% Thyroid Dysfunction) and 10% a uterine factor (4% Cervical Incompetence, 2% Fibroids, 2% Synechiae and 2% Anomalies). APS and Thrombophilias constituted 3% and 2% of patients respectively. The BMI (mean +/- SD) amongst patients with Unexplained RM, PCOS and IGT were 28.85 +/- 5.95, 30.86 +/- 7.79 and 33.40 +/- 6.47 respectively. Patients with IGT had significantly higher mean BMI in comparison to those with Unexplained RM (p < 0.0001)*** and PCOS (p < 0.001)**. Conclusion: PCOS, IGT and Type II Diabetes are all likely surrogates for elevated BMI and constitute 70% of those women with RM and identified associated medical disorders. In our population, BMI seems to have a substantial impact on recurrent pregnancy loss and future studies should interrogate its effect on recurrent miscarriage. (C) 2017 Elsevier B.V. All rights reserved.
引用
收藏
页码:91 / 96
页数:6
相关论文
共 35 条
[11]   Does Immunotherapy for Treatment of Reproductive Failure Enhance Live Births? [J].
Coulam, Carolyn B. ;
Acacio, Brian .
AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2012, 67 (04) :296-303
[12]   Psychological distress among women suffering from couple infertility in South Africa: a quantitative assessment [J].
Dyer, SJ ;
Abrahams, N ;
Mokoena, NE ;
Lombard, CJ ;
van der Spuy, ZM .
HUMAN REPRODUCTION, 2005, 20 (07) :1938-1943
[13]   Cost-effectiveness of cytogenetic evaluation of products of conception in the patient with a second pregnancy loss [J].
Foyouzi, Nastaran ;
Cedars, Marcelle I. ;
Huddleston, Heather G. .
FERTILITY AND STERILITY, 2012, 98 (01) :151-155.e3
[14]   Understanding Reasons for and Outcomes of Patients Lost to Follow-Up in Antiretroviral Therapy Programs in Africa Through a Sampling-Based Approach [J].
Geng, Elvin H. ;
Bangsberg, David R. ;
Musinguzi, Nicolas ;
Emenyonu, Nneka ;
Bwana, Mwebesa Bosco ;
Yiannoutsos, Constantin T. ;
Glidden, David V. ;
Deeks, Steven G. ;
Martin, Jeffrey N. .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2010, 53 (03) :405-411
[15]   Marriage and Cohabitation Outcomes After Pregnancy Loss [J].
Gold, Katherine J. ;
Sen, Ananda ;
Hayward, Rodney A. .
PEDIATRICS, 2010, 125 (05) :E1202-E1207
[16]   The one-stop recurrent miscarriage clinic: an evaluation of its effectiveness and outcome [J].
Habayeb, OMH ;
Konje, JC .
HUMAN REPRODUCTION, 2004, 19 (12) :2952-2958
[17]   A CYTOGENETIC STUDY OF 1000 SPONTANEOUS-ABORTIONS [J].
HASSOLD, T ;
CHEN, N ;
FUNKHOUSER, J ;
JOOSS, T ;
MANUEL, B ;
MATSUURA, J ;
MATSUYAMA, A ;
WILSON, C ;
YAMANE, JA ;
JACOBS, PA .
ANNALS OF HUMAN GENETICS, 1980, 44 (OCT) :151-178
[18]   Diagnostic factors identified in 1020 women with two versus three or more recurrent pregnancy losses [J].
Jaslow, Carolyn R. ;
Carney, Judi L. ;
Kutteh, William H. .
FERTILITY AND STERILITY, 2010, 93 (04) :1234-1243
[19]   Evidence-based guidelines for the investigation and medical treatment of recurrent miscarriage [J].
Jauniaux, Eric ;
Farquharson, Roy G. ;
Christiansen, Ole B. ;
Exalto, Niek .
HUMAN REPRODUCTION, 2006, 21 (09) :2216-2222
[20]   Terminology for pregnancy loss prior to viability: a consensus statement from the ESHRE early pregnancy special interest group [J].
Kolte, A. M. ;
Bernardi, L. A. ;
Christiansen, O. B. ;
Quenby, S. ;
Farquharsons, R. G. ;
Goddijn, M. ;
Stephenson, M. D. .
HUMAN REPRODUCTION, 2015, 30 (03) :495-498